QA: Esperion Therapeutics Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001434868_2025_Esperion_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001434868, Esperion Therapeutics Inc

  xvar xval
0 AssetsCurrent 337,998,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 254,000
3 remainder_Assets 5,569,000
4 LiabilitiesCurrent 246,233,000
5 LiabilitiesNoncurrent 2,570,000
6 remainder_Liabilities 483,740,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 164,895,414
9 ResearchAndDevelopmentExpense 10,493,044
10 remainder_Expenses 246,461,519
11 remainder_Revenues 377,845,682
12 remainder_NetIncome 5,079,054
13 remainder_ComprehensiveNetIncome 976
  yvar yval
0 Assets 343,821,000
1 Liabilities 732,543,000
2 Expenses 421,849,977
3 Revenues 377,845,682
4 StockholdersEquity -388,722,000
5 NetIncome -38,925,241
6 ComprehensiveNetIncome -38,924,753
7 BaseVar 940,569,844
8 EconomicCapitalRatiobeforeLimitedLiability -1.65
9 EconomicCapitalRatio 1.14

Edgar->Model Mapping

Feature Distribution

Change over Time